Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Harvard Business School
McKesson
Baxter
Boehringer Ingelheim

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Abraxis Pharm Company Profile

See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for ABRAXIS PHARM, and what generic and branded alternatives to ABRAXIS PHARM drugs are available?

ABRAXIS PHARM has one hundred and thirteen approved drugs.

There is one tentative approval on ABRAXIS PHARM drugs.

Summary for Abraxis Pharm
US Patents:0
Tradenames:63
Ingredients:60
NDAs:113

Drugs and US Patents for Abraxis Pharm

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abraxis Pharm PROCAINE HYDROCHLORIDE procaine hydrochloride INJECTABLE;INJECTION 080384-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Abraxis Pharm CEFAZOLIN SODIUM cefazolin sodium INJECTABLE;INJECTION 062688-002 Nov 17, 1986 DISCN No No   Start Trial   Start Trial
Abraxis Pharm NALOXONE HYDROCHLORIDE naloxone hydrochloride INJECTABLE;INJECTION 070648-001 Nov 17, 1986 DISCN No No   Start Trial   Start Trial
Abraxis Pharm POTASSIUM CHLORIDE potassium chloride INJECTABLE;INJECTION 084290-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial
Abraxis Pharm FLUOROURACIL fluorouracil INJECTABLE;INJECTION 089519-001 Mar 12, 1987 DISCN No No   Start Trial   Start Trial
Abraxis Pharm METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 088677-001 Jun 8, 1984 DISCN No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Boehringer Ingelheim
Colorcon
Medtronic
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.